Loading...
7‐Step Flow Synthesis of the HIV Integrase Inhibitor Dolutegravir
Dolutegravir (DTG), an important active pharmaceutical ingredient (API) used in combination therapy for the treatment of HIV, has been synthesized in continuous flow. By adapting the reported GlaxoSmithKline process chemistry batch route for Cabotegravir, DTG was produced in 4.5 h in sequential flow...
Na minha lista:
| Udgivet i: | Angew Chem Int Ed Engl |
|---|---|
| Main Authors: | , , , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
John Wiley and Sons Inc.
2018
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6033037/ https://ncbi.nlm.nih.gov/pubmed/29756689 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/anie.201802256 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|